A phase 3 trial found that PSMA PET-CT after equivocal MRI halves the prostate biopsy rate in men at high clinical risk for prostate cancer. In men with high clinical risk and equivocal prostate ...
Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Douglas M. Dahl, MD, Chief of the Division of Urologic Oncology at Massachusetts General Hospital and Associate Professor of Surgery at Harvard Medical School in Boston, Massachusetts, said PSMA PET ...
Rarely has a footnote garnered so much positive attention, but a reference in the newly updated prostate cancer guidelines from the National Comprehensive Cancer Network (NCCN) has prostate cancer ...
Socio-economic disparities in prostate cancer hospitalizations and outcomes across the United States. Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC) ...
An overview of metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA in mCRPC. Alicia Morgans, MD: Welcome to the CURE Connections® program on radiopharmaceutical PSMA [prostate ...
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
Prostate-specific membrane antigen (PSMA) is a protein found in small amounts in your prostate gland. When you have prostate cancer, you have many times more PSMA than normal. This makes PSMA a good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results